218TiP A phase Ib study of irinotecan, bevacizumab and...

Annals of Oncology 2016 / 12 Vol. 27; Iss. suppl_9

218TiP A phase Ib study of irinotecan, bevacizumab and biweekly TAS-102 in Japanese patients with metastatic colorectal cancer refractory to fluoropyrimidine and oxaliplation (MODURATE)

Taniguchi, H., Narita, Y., Kadowaki, S., Ura, T., Ando, M., Muro, K., Hamauchi, S., Tsushima, T., Yokota, T., Todaka, A., Machida, N., Fukutomi, A., Onozawa, Y., Yasui, H., Mori, K., Yamazaki, K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw581.050
Date:
December, 2016
File:
PDF, 64 KB
2016
Conversion to is in progress
Conversion to is failed